Table II.
Progression to COPD in Active Smokers with Normal Spirometry/Low DLCO vs Active Smokers with Normal Spirometry/Normal DLCO1
| At end of evaluation period |
||
|---|---|---|
| Group2 | % normal | % with COPD |
| Normal spirometry, normal DLCO | 97% (57/59) | 3% (2/59) |
| Normal spirometry, low DLCO | 78% (36/46) | 22% (10/46) |
| p value3 | 0.009 | |
Fifty-nine active smokers with normal spirometry/normal diffusion capacity, and 46 active smokers with normal spirometry/low diffusion capacity (DLCO) were followed over time with full lung function studies to determine the rate of progression to COPD.
Individuals with normal spirometry, lung volumes and normal DLCO were followed for 45±20 months. Individuals with normal spirometry, lung volumes but low DLCO were followed for 41±31months (p>0.4).
Chi-square.